WO2008015220A8 - Granule and orally disintegrating tablet comprising oxycodone - Google Patents

Granule and orally disintegrating tablet comprising oxycodone

Info

Publication number
WO2008015220A8
WO2008015220A8 PCT/EP2007/057912 EP2007057912W WO2008015220A8 WO 2008015220 A8 WO2008015220 A8 WO 2008015220A8 EP 2007057912 W EP2007057912 W EP 2007057912W WO 2008015220 A8 WO2008015220 A8 WO 2008015220A8
Authority
WO
WIPO (PCT)
Prior art keywords
oxycodone
orally disintegrating
granule
disintegrating tablet
granules
Prior art date
Application number
PCT/EP2007/057912
Other languages
French (fr)
Other versions
WO2008015220A1 (en
Inventor
Didier Hoarau
Original Assignee
Ethypharm Sa
Didier Hoarau
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38752477&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2008015220(A8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to ES07788099.5T priority Critical patent/ES2667944T3/en
Priority to EP07788099.5A priority patent/EP2046285B1/en
Priority to EA200900260A priority patent/EA017832B1/en
Priority to AU2007280470A priority patent/AU2007280470B2/en
Priority to MX2009001294A priority patent/MX2009001294A/en
Priority to CA2659122A priority patent/CA2659122C/en
Priority to US12/376,060 priority patent/US8465776B2/en
Application filed by Ethypharm Sa, Didier Hoarau filed Critical Ethypharm Sa
Priority to NZ574544A priority patent/NZ574544A/en
Priority to BRPI0714514A priority patent/BRPI0714514B8/en
Priority to CN2007800363003A priority patent/CN101534792B/en
Priority to JP2009522247A priority patent/JP5421775B2/en
Priority to KR1020097002243A priority patent/KR101445757B1/en
Publication of WO2008015220A1 publication Critical patent/WO2008015220A1/en
Publication of WO2008015220A8 publication Critical patent/WO2008015220A8/en
Priority to IL196741A priority patent/IL196741A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Abstract

The present invention relates to granules comprising oxycodone, as well as to orally disintegrating tablets including same and optionally acetaminophen.
PCT/EP2007/057912 2006-08-04 2007-07-31 Granule and orally disintegrating tablet comprising oxycodone WO2008015220A1 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
KR1020097002243A KR101445757B1 (en) 2006-08-04 2007-07-31 Granule and orally disintegrating tablet comprising oxycodone
US12/376,060 US8465776B2 (en) 2006-08-04 2007-07-31 Granule and orally disintegrating tablet comprising oxycodone
EA200900260A EA017832B1 (en) 2006-08-04 2007-07-31 Granule and orally disintegrating tablet comprising oxycodone
AU2007280470A AU2007280470B2 (en) 2006-08-04 2007-07-31 Granule and orally disintegrating tablet comprising oxycodone
NZ574544A NZ574544A (en) 2006-08-04 2007-07-31 Granule and orally disintegrating tablet comprising oxycodone
CA2659122A CA2659122C (en) 2006-08-04 2007-07-31 Granule and orally disintegrating tablet comprising oxycodone
EP07788099.5A EP2046285B1 (en) 2006-08-04 2007-07-31 Granule and orally disintegrating tablet comprising oxycodone
ES07788099.5T ES2667944T3 (en) 2006-08-04 2007-07-31 Orodispersible granules and tablets containing oxycodone
MX2009001294A MX2009001294A (en) 2006-08-04 2007-07-31 Granule and orally disintegrating tablet comprising oxycodone.
BRPI0714514A BRPI0714514B8 (en) 2006-08-04 2007-07-31 granule comprising oxycodone coated core as well as tablet for oral disintegration and its manufacturing process
CN2007800363003A CN101534792B (en) 2006-08-04 2007-07-31 Granule and orally disintegrating tablet comprising oxycodone
JP2009522247A JP5421775B2 (en) 2006-08-04 2007-07-31 Oxycodone-containing granules and orally disintegrating tablets
IL196741A IL196741A (en) 2006-08-04 2009-01-27 Granules and orally disinitegrating tablet comprising oxycodone

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82144906P 2006-08-04 2006-08-04
US60/821,449 2006-08-04

Publications (2)

Publication Number Publication Date
WO2008015220A1 WO2008015220A1 (en) 2008-02-07
WO2008015220A8 true WO2008015220A8 (en) 2008-04-03

Family

ID=38752477

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2007/057912 WO2008015220A1 (en) 2006-08-04 2007-07-31 Granule and orally disintegrating tablet comprising oxycodone

Country Status (15)

Country Link
US (1) US8465776B2 (en)
EP (1) EP2046285B1 (en)
JP (1) JP5421775B2 (en)
KR (1) KR101445757B1 (en)
CN (1) CN101534792B (en)
AU (1) AU2007280470B2 (en)
BR (1) BRPI0714514B8 (en)
CA (1) CA2659122C (en)
EA (1) EA017832B1 (en)
ES (1) ES2667944T3 (en)
IL (1) IL196741A (en)
MX (1) MX2009001294A (en)
NZ (1) NZ574544A (en)
WO (1) WO2008015220A1 (en)
ZA (1) ZA200900640B (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040253310A1 (en) 2001-09-21 2004-12-16 Gina Fischer Morphine polymer release system
US20040234602A1 (en) 2001-09-21 2004-11-25 Gina Fischer Polymer release system
ATE495732T1 (en) 2003-03-26 2011-02-15 Egalet As CONTROLLED RELEASE MORPHINE SYSTEM
JP5497435B2 (en) * 2006-08-04 2014-05-21 エチファーム Multilayer orally disintegrating tablets
EP2155167A2 (en) 2007-06-04 2010-02-24 Egalet A/S Controlled release pharmaceutical compositions for prolonged effect
CN102196811B (en) * 2008-10-24 2014-03-19 东丽株式会社 Stable tablet containing 4,5-epoxymorphinan derivative
NZ594207A (en) 2009-02-06 2013-03-28 Egalet Ltd Immediate release composition resistant to abuse by intake of alcohol
MX2011011480A (en) * 2009-05-01 2012-02-28 Aptalis Pharmatech Inc Orally disintegrating tablet compositions comprising combinations of non-opioid and opioid analgesics.
NZ603579A (en) 2009-06-24 2014-02-28 Egalet Ltd Controlled release formulations
US9198861B2 (en) 2009-12-22 2015-12-01 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
US20110150989A1 (en) * 2009-12-22 2011-06-23 Mallinkckrodt Inc. Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans
US20130240384A1 (en) * 2010-08-18 2013-09-19 Purdue Pharma L.P. Vacuum Avoiding Packaging Systems and Methods Thereof
CN102178657B (en) * 2011-04-11 2017-05-31 浙江华海药业股份有限公司 A kind of Olanzapine oral disnitegration tablet
US9050335B1 (en) 2011-05-17 2015-06-09 Mallinckrodt Llc Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia
US8858963B1 (en) 2011-05-17 2014-10-14 Mallinckrodt Llc Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
US9827191B2 (en) 2012-05-03 2017-11-28 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
WO2013166408A1 (en) 2012-05-03 2013-11-07 Kala Pharmaceuticals, Inc. Pharmaceutical nanoparticles showing improved mucosal transport
KR102140989B1 (en) 2012-05-03 2020-08-04 칼라 파마슈티컬스, 인크. Pharmaceutical nanoparticles showing improved mucosal transport
US11596599B2 (en) 2012-05-03 2023-03-07 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
CA2877183A1 (en) 2012-07-06 2014-01-09 Egalet Ltd. Abuse deterrent pharmaceutical compositions for controlled release
CA2877774C (en) 2012-07-12 2017-07-18 Mallinckrodt Llc Extended release, abuse deterrent pharmaceutical compositions
KR101340733B1 (en) * 2012-12-31 2013-12-12 (주) 에프엔지리서치 Novel microgranule preparations
EP2801349A1 (en) 2013-05-06 2014-11-12 Siegfried AG Oral Pharmaceutical Formulation
US10195153B2 (en) 2013-08-12 2019-02-05 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US20150118300A1 (en) 2013-10-31 2015-04-30 Cima Labs Inc. Immediate Release Abuse-Deterrent Granulated Dosage Forms
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
EP3169315B1 (en) 2014-07-17 2020-06-24 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
US20160106737A1 (en) 2014-10-20 2016-04-21 Pharmaceutical Manufacturing Research Services, Inc. Extended Release Abuse Deterrent Liquid Fill Dosage Form
GR1008992B (en) 2015-12-17 2017-03-23 Verisfield (Uk) Ltd, Υποκαταστημα Ελλαδας, Εμπορια Φαρμακων Oral pharmaceutical composition in the form of granules comprising metronidazole or derivatives thereofand a taste-masking agent
US20190054029A1 (en) * 2016-02-23 2019-02-21 Nipro Corporation Pharmaceutical composition particles, orally disintegrating preparation including same, and method for producing pharmaceutical composition particles
JP6915258B2 (en) * 2016-10-21 2021-08-04 ニプロ株式会社 Pharmaceutical composition particles, orally disintegrating preparation containing them, method for producing pharmaceutical composition particles
KR102120720B1 (en) * 2018-07-16 2020-06-10 연성정밀화학(주) Orally Disintegrating Tablet Comprising Nalfurafine
CN109512796A (en) * 2018-12-26 2019-03-26 甘肃普安制药股份有限公司 A kind of ammonia phenol oxycodone capsules fill method
WO2020225773A1 (en) 2019-05-07 2020-11-12 Clexio Biosciences Ltd. Abuse-deterrent dosage forms containing esketamine

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464632C1 (en) * 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
FR2679451B1 (en) 1991-07-22 1994-09-09 Prographarm Laboratoires MULTIPARTICLE TABLET WITH RAPID DELIVERY.
US5266331A (en) * 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5286493A (en) 1992-01-27 1994-02-15 Euroceltique, S.A. Stabilized controlled release formulations having acrylic polymer coating
CA2128820A1 (en) 1993-07-27 1995-01-28 Walter G. Gowan, Jr. Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof
EP0647448A1 (en) * 1993-10-07 1995-04-12 Euroceltique S.A. Orally administrable opioid formulations having extended duration of effect
US6024981A (en) 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
FR2766089B1 (en) * 1997-07-21 2000-06-02 Prographarm Lab IMPROVED MULTIPARTICULAR TABLET WITH RAPID DELIVERY
KR20010041609A (en) 1998-03-06 2001-05-25 유란드 인터내셔날 에스.피.아. Fast disintegrating tablets
TW585786B (en) * 1998-07-28 2004-05-01 Takeda Chemical Industries Ltd Lansoprazole-containing rapidly disintegrable solid pharmaceutical composition
FR2785538B1 (en) 1998-11-06 2004-04-09 Prographarm Laboratoires PERFECTED QUICK DELIVERY TABLET
US6740341B1 (en) * 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
JP2002530322A (en) * 1998-11-25 2002-09-17 シーマ・ラブス・インコーポレイテッド Taste masking rapid release coating system
FR2790387B1 (en) 1999-03-01 2001-05-18 Prographarm Laboratoires ORODISPERSIBLE TABLET HAVING LOW FRIABILITY AND PROCESS FOR THE PREPARATION THEREOF
PT1416842E (en) 2001-07-18 2009-03-31 Euro Celtique Sa Pharmaceutical combinations of oxycodone and naloxone
US20030044458A1 (en) * 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
IL163911A0 (en) * 2002-03-14 2005-12-18 Euro Celtique Sa Naltrexone hydrochloride compositions
FR2850576B1 (en) 2003-02-05 2007-03-23 Ethypharm Sa COMPOSITION COMPRISING A MIXTURE OF ACTIVE INGREDIENTS AND PROCESS FOR PREPARING THE SAME
US20060275364A1 (en) * 2005-05-26 2006-12-07 Ahmed Salah U Flexible Solid Dosage Forms and Methods of Making and Using the Same
US8900637B2 (en) * 2005-12-02 2014-12-02 Lupin Limited Stable taste masked formulations of cephalosporins
JP5497435B2 (en) * 2006-08-04 2014-05-21 エチファーム Multilayer orally disintegrating tablets

Also Published As

Publication number Publication date
BRPI0714514B1 (en) 2020-01-07
CN101534792B (en) 2013-02-20
CN101534792A (en) 2009-09-16
WO2008015220A1 (en) 2008-02-07
IL196741A0 (en) 2009-11-18
NZ574544A (en) 2011-12-22
ES2667944T3 (en) 2018-05-16
ZA200900640B (en) 2010-06-30
AU2007280470B2 (en) 2013-03-14
BRPI0714514B8 (en) 2021-05-25
EA017832B1 (en) 2013-03-29
EP2046285A1 (en) 2009-04-15
CA2659122C (en) 2016-08-23
JP2009545560A (en) 2009-12-24
KR101445757B1 (en) 2014-10-02
US8465776B2 (en) 2013-06-18
AU2007280470A1 (en) 2008-02-07
IL196741A (en) 2015-05-31
BRPI0714514A2 (en) 2013-07-02
KR20090034372A (en) 2009-04-07
EA200900260A1 (en) 2009-06-30
MX2009001294A (en) 2009-05-21
JP5421775B2 (en) 2014-02-19
EP2046285B1 (en) 2018-02-21
CA2659122A1 (en) 2008-02-07
US20090304792A1 (en) 2009-12-10

Similar Documents

Publication Publication Date Title
WO2008015220A8 (en) Granule and orally disintegrating tablet comprising oxycodone
GB2456989B (en) Granules, tablets and granulation
EG25147A (en) Process for the manufacture of 1,2-dichloroethane.
IL184526A0 (en) Substituted aminomethylene sulphonamides, production and use thereof as medicaments
EP1905430A4 (en) Tablet
WO2008046581A3 (en) Substituted tetrahydropyrrolopyrazine compounds and use thereof in medicaments
EP1923074A4 (en) Orally disintegratable tablet
EP1904696A4 (en) Roofing product
ZA200703376B (en) Dibenzodiazepinone analogues, processes for their production and their use as pharmaceuticals
GB0606192D0 (en) Granulated sugar product
EP1852109A4 (en) Xylitol granules capable of directly being pressed into tablets and preparation process thereof
IL193384A0 (en) Substituted prolinamides, their preparation and their use as pharmaceuticals
WO2008127382A3 (en) Computational design of ribozymes
ZA200902712B (en) Granules, tablets and granulation
EP1867324A4 (en) Tablet
AP2343A (en) Rapidly disintegrating taste-masked tablet.
ZA200707937B (en) Soluble speckle granule
佚名 et al. Two Pieces of Cake
TH94624B (en) Television receiver
PL379680A1 (en) Aluminium granulated product
AU2005904631A0 (en) Word Processing System
AU2005904776A0 (en) Layered tablet
AU2005905203A0 (en) Infra-red alert system
GB0505596D0 (en) Process, compounds and their uses
AU2005904866A0 (en) Pipe Manufacture

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200780036300.3

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07788099

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2659122

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2007280470

Country of ref document: AU

Ref document number: 209/MUMNP/2009

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 574544

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 12376060

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2009522247

Country of ref document: JP

Ref document number: MX/A/2009/001294

Country of ref document: MX

Ref document number: 1020097002243

Country of ref document: KR

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007788099

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2007280470

Country of ref document: AU

Date of ref document: 20070731

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 200900260

Country of ref document: EA

NENP Non-entry into the national phase

Ref country code: RU

ENP Entry into the national phase

Ref document number: PI0714514

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20090202